NYSE · CIK 0000313143
HAE HAEMONETICS CORP
Insider trading from SEC Form 4. Last filing Sep 24, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Signals
Open-market buys and sells at HAEMONETICS CORP, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 51 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | Laurie A. Miller SVP, Human Resources | FTax withholding Common Stock | -238 | $49.95 | $12k | 28,925 | Sep 24, 2025 |
| Jul 24, 2025 | Robert E Abernathy director | AGrant or award Common Stock | +2,693 | - | - | 24,981 | Jul 25, 2025 |
| Jul 24, 2025 | Diane M Bryant director | AGrant or award Common Stock | +2,693 | - | - | 7,126 | Jul 25, 2025 |
| Jul 24, 2025 | Michael J Coyle director | AGrant or award Common Stock | +2,693 | - | - | 15,394 | Jul 25, 2025 |
| Jul 24, 2025 | Charles J Dockendorff director | AGrant or award Common Stock | +2,693 | - | - | 7,126 | Jul 25, 2025 |
| Jul 24, 2025 | Lloyd Emerson Johnson director | AGrant or award Common Stock | +2,693 | - | - | 12,933 | Jul 25, 2025 |
| Jul 24, 2025 | Mark W Kroll director | AGrant or award Common Stock | +2,693 | - | - | 23,357 | Jul 25, 2025 |
| Jul 24, 2025 | Claire Pomeroy director | AGrant or award Common Stock | +2,693 | - | - | 16,872 | Jul 25, 2025 |
| Jul 24, 2025 | Ellen M Zane director | AGrant or award Common Stock | +2,693 | - | - | 19,373 | Jul 25, 2025 |
| May 16, 2025 | Roy Galvin EVP, Chief Commercial Officer | AGrant or award Common Stock | +5,689 | - | - | 12,932 | Jun 13, 2025 |
| May 16, 2025 | Michelle L Basil EVP and General Counsel | AGrant or award Common Stock | +6,755 | - | - | 35,233 | Jun 13, 2025 |
| May 16, 2025 | Roy Galvin EVP, Chief Commercial Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +12,317 | $0.00 | $0 | 12,317 | Jun 13, 2025 |
| May 16, 2025 | Michelle L Basil EVP and General Counsel | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +14,626 | $0.00 | $0 | 14,626 | Jun 13, 2025 |
| Jun 5, 2025 | Laurie A. Miller SVP, Human Resources | AGrant or award Common Stock | +3,195 | - | - | 29,163 | Jun 9, 2025 |
| Jun 5, 2025 | Farris Maryanne Maunsell VP, Chief Accounting Officer | AGrant or award Common Stock | +2,662 | - | - | 4,478 | Jun 9, 2025 |
| May 30, 2025 | James DArecca EVP, Chief Financial Officer | AGrant or award Common Stock | +12,221 | $0.00 | $0 | 34,156 | Jun 3, 2025 |
| May 30, 2025 | Michelle L Basil EVP and General Counsel | AGrant or award Common Stock | +15,554 | $0.00 | $0 | 49,721 | Jun 3, 2025 |
| May 30, 2025 | Laurie A. Miller SVP, Human Resources | AGrant or award Common Stock | +7,777 | $0.00 | $0 | 28,251 | Jun 3, 2025 |
| May 30, 2025 | Christopher Simon President & CEO | AGrant or award Common Stock | +66,666 | $0.00 | $0 | 401,778 | Jun 3, 2025 |
| May 30, 2025 | James DArecca EVP, Chief Financial Officer | FTax withholding Common Stock | -5,864 | $69.38 | $407k | 28,292 | Jun 3, 2025 |
| May 30, 2025 | Christopher Simon President & CEO | FTax withholding Common Stock | -26,234 | $69.38 | $1.8M | 375,544 | Jun 3, 2025 |
| May 30, 2025 | Laurie A. Miller SVP, Human Resources | FTax withholding Common Stock | -2,283 | $69.38 | $158k | 25,968 | Jun 3, 2025 |
| May 30, 2025 | Michelle L Basil EVP and General Counsel | FTax withholding Common Stock | -7,469 | $69.38 | $518k | 42,252 | Jun 3, 2025 |
| May 16, 2025 | James DArecca EVP, Chief Financial Officer | AGrant or award Common Stock | +7,111 | - | - | 21,935 | May 20, 2025 |
| May 16, 2025 | Farris Maryanne Maunsell VP, Chief Accounting Officer | AGrant or award Common Stock | +800 | - | - | 1,816 | May 20, 2025 |
| May 16, 2025 | Laurie A. Miller SVP, Human Resources | AGrant or award Common Stock | +3,200 | - | - | 20,474 | May 20, 2025 |
| May 16, 2025 | Christopher Simon President & CEO | AGrant or award Common Stock | +21,405 | - | - | 335,112 | May 20, 2025 |
| May 16, 2025 | Roy Galvin President, Global Plasma & BC | AGrant or award Common Stock | +6,755 | - | - | 13,998 | May 20, 2025 |
| May 16, 2025 | Michelle L Basil EVP and General Counsel | AGrant or award Common Stock | +5,689 | - | - | 34,167 | May 20, 2025 |
| May 16, 2025 | Frank Chan EVP, Chief Operating Officer | AGrant or award Common Stock | +5,689 | - | - | 5,689 | May 20, 2025 |
| May 16, 2025 | Roy Galvin President, Global Plasma & BC | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +14,626 | $0.00 | $0 | 14,626 | May 20, 2025 |
| May 16, 2025 | Michelle L Basil EVP and General Counsel | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +12,317 | $0.00 | $0 | 12,317 | May 20, 2025 |
| May 16, 2025 | Farris Maryanne Maunsell VP, Chief Accounting Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +1,732 | $0.00 | $0 | 1,732 | May 20, 2025 |
| May 16, 2025 | Frank Chan EVP, Chief Operating Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +12,317 | $0.00 | $0 | 12,317 | May 20, 2025 |
| May 16, 2025 | Laurie A. Miller SVP, Human Resources | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +6,928 | $0.00 | $0 | 6,928 | May 20, 2025 |
| May 16, 2025 | Christopher Simon President & CEO | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +46,342 | $0.00 | $0 | 46,342 | May 20, 2025 |
| May 16, 2025 | James DArecca EVP, Chief Financial Officer | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +15,396 | $0.00 | $0 | 15,396 | May 20, 2025 |
| May 15, 2025 | Michelle L Basil EVP and General Counsel | FTax withholding Common Stock | -622 | $69.38 | $43k | 30,635 | May 19, 2025 |
| May 15, 2025 | James DArecca EVP, Chief Financial Officer | FTax withholding Common Stock | -622 | $69.38 | $43k | 16,070 | May 19, 2025 |
| May 15, 2025 | Roy Galvin President, Global Plasma & BC | FTax withholding Common Stock | -201 | $69.38 | $14k | 7,500 | May 19, 2025 |
| May 15, 2025 | Christopher Simon President & CEO | FTax withholding Common Stock | -2,391 | $69.38 | $166k | 320,796 | May 19, 2025 |
| May 15, 2025 | Laurie A. Miller SVP, Human Resources | FTax withholding Common Stock | -206 | $69.38 | $14k | 17,751 | May 19, 2025 |
| May 15, 2025 | Farris Maryanne Maunsell VP, Chief Accounting Officer | FTax withholding Common Stock | -60 | $69.38 | $4,163 | 1,084 | May 19, 2025 |
| May 16, 2025 | James DArecca EVP, Chief Financial Officer | FTax withholding Common Stock | -1,246 | $70.31 | $88k | 14,824 | May 19, 2025 |
| May 16, 2025 | Farris Maryanne Maunsell VP, Chief Accounting Officer | FTax withholding Common Stock | -68 | $70.31 | $4,781 | 1,016 | May 19, 2025 |
| May 16, 2025 | Laurie A. Miller SVP, Human Resources | FTax withholding Common Stock | -477 | $70.31 | $34k | 17,274 | May 19, 2025 |
| May 16, 2025 | Christopher Simon President & CEO | FTax withholding Common Stock | -7,089 | $70.31 | $498k | 313,707 | May 19, 2025 |
| May 16, 2025 | Roy Galvin President, Global Plasma & BC | FTax withholding Common Stock | -257 | $70.31 | $18k | 7,243 | May 19, 2025 |
| May 16, 2025 | Michelle L Basil EVP and General Counsel | FTax withholding Common Stock | -2,157 | $70.31 | $152k | 28,478 | May 19, 2025 |
| May 2, 2025 | James DArecca EVP, Chief Financial Officer | FTax withholding Common Stock | -654 | $63.85 | $42k | 16,692 | May 5, 2025 |
| Nov 1, 2024 | Roy Galvin President, Global Plasma & BC | FTax withholding Common Stock | -161 | $71.48 | $12k | 7,373 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert E Abernathydirector
- Michelle L BasilEVP and General Counsel
- Diane M Bryantdirector
- Michael J Coyledirector
- Frank ChanEVP, Chief Operating Officer
- James DAreccaEVP, Chief Financial Officer
- Charles J Dockendorffdirector
- Roy GalvinEVP, Chief Commercial Officer
- Lloyd Emerson Johnsondirector
- Mark W Krolldirector
- Farris Maryanne MaunsellVP, Chief Accounting Officer
- Laurie A. MillerSVP, Human Resources
- Claire Pomeroydirector
- Christopher SimonPresident & CEO
- Ellen M Zanedirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.